Samuel Blumenfeld

Samuel Morry Blumenfeld was the founder of MediTech Partners, Inc., founded in 2003, where the title held was Principal from 2003 to 2010.
Dr. Blumenfeld is the founder of MediTech Advisors LLC, founded in 2003, holding the title Director & Founding Partner since 2003.
Current jobs include President & Chief Executive Officer at Quescon Consultants Ltd. since 2012; Director at Nanox Imaging Plc; Director at Aposense Ltd. since 2007; Director & Founding Partner at Meditech Advisors Management LLC; Director at B.C.M.
Meditech Advisors Ltd.; Director at S.D.
Sight Diagnostics Ltd.; Director at Momentis Surgical Ltd. since 2016; Director at Illumigyn Ltd.; Independent Director at Alpha Tau Medical Ltd. since 2016; Member-Governors Board at The Hebrew University of Jerusalem; and Partner-MedTech Investments at OurCrowd Squared LP.
Former jobs include Independent Director at MAKO Surgical Corp.
from 2005 to 2013; Director at ONI Medical Systems, Inc.; Non-Executive Director at Oridion Systems Ltd. from 2005 to 2012; Director at Yissum Research Development Co. Ltd.; Managing Director at GE Medical Systems Information Technologies, Inc.; Director at Dune Medical Devices Ltd.; Independent Director at Itamar Medical Ltd. from 2010 to 2017; Managing Director at GE Medical Systems Israel Ltd. from 1968 to 2002; Director at Itamar Medical, Inc.; Principal at GE Healthcare Ltd. (United Kingdom) in 2002; Venture Partner at OurCrowd Management Ltd.; and Principal at Ziegler Meditech Partners LLC.
Education includes a doctorate degree conferred in 1967, a graduate degree in 1961, and an undergraduate degree in 1960, all from the University of Toronto.